One example is hereditary diffuse gastric cancer associated with CDH1, where there is a high likelihood of gastric cancer and a significant risk of morbidity, and where gastrectomy (i.e., removal of the stomach) is the sole effective intervention to reduce the risk for developing gastric cancer, which surveillance is not effective at detecting at early stages. Here, CDH1 is linked to gastric cancer.